Page 3 - Grovet Finance

Sabrina and Koen had a great visit at Altano Gruppe in Dülmen (DU) last week.

Thank you for having us, we looking forward to a great cooperation!

Marketing employee, Esmé Blankestijn

My name is Esmé Blankestijn and since December 2021 I am working in the Marketing team at Grovet.
I graduated as a paraveterinairy and after 7 years of working in practice, I wanted something different.
In my daily life I can be found between the horses and on social media. I have my own jumping horse that I’m training and I also have a big Instagram account, that’s why I decided to switch from Veterinary Assistant to Marketeer.

And I like it a lot!

June 1, 2021

Zoetis Inc., the world’s leading animal health company, announced it has acquired the assets to Owl Manor’s range of devices for use in regenerative medicine therapies in equine and canine patients, which includes Pro-Stride® APS, Restigen® PRP, CenTrate® BMA and related products.  Zoetis will be immediately incorporating this portfolio into the Zoetis Equine family of horse care products. 

Grovet has been a proud channel partner of Owl Manor Veterinary since 2016 with exclusive rights for Europe, Middle East and South Africa. We are pleased to announce our partnership with Zoetis, and that our role in providing and supplying this portfolio of products will remain the same. 

At Grovet, we look forward continuing to broaden the foothold in our markets with the Pro-Stride APS, Restigen PRP and CenTrate BMA suite of products.

Yours sincerely,

Koen Schmitz

CEO

For Reference: Zoetis Press Release